Literature DB >> 9112258

Induction of the differentiation of HL-60 promyelocytic leukemia cells by curcumin in combination with low levels of vitamin D3.

J A Sokoloski1, K Shyam, A C Sartorelli.   

Abstract

Previous studies have shown that an antisense phosphorothioate oligonucleotide to the Rel A subunit of NF- kappa B, as well as vitamin E and related antioxidants, significantly enhanced the differentiation of HL-60 leukemia cells when combined with low levels of 1 alpha, 25-dihydroxyvitamin D3 (vitamin D3) an effect accompanied by a marked inhibition of the transcription factor, NF-kappa B. Curcumin, a potent inhibitor of tumor promotion and of tumor cell growth, has also been shown to have antioxidant properties and to inhibit NF-kappa b. to ascertain whether curcumin would also enhance the differentiation of HL-60 leukemia cells produced by vitamin D3, presumably by interfering with NF- kappa B activity, the effects of curcumin on the differentiation of HL-60 cells produced by low levels of vitamin D3 were measured. Curcumin used alone did not produce a significant degree of differentiation of HL-60 cells; however, this agent markedly enhanced the expression of differentiation markers induced by low levels of vitamin D3. Curcumin also increased the differentiation of HL-60 cells when combined with vitamin D analogues (1,25-dihydroxy-16-ene-23-yne vitamin D3 and 1,25-dihydroxy-16-ene vitamin D3) that share the receptor binding properties of vitamin D3, whereas as vitamin D analogue (1,25-dihydroxy-16,23-diene vitamin D3) that caused significant calcium mobilization, but was less effective than vitamin d3 in binding the receptor, did not cause the differentiation of HL-60 cells in the presence or absence of curcumin. Several dietary compounds structurally related to curcumin (i.e., caffeic acid, chlorogenic acid, and ferulic acid) did not increase the differentiation of HL-60 cells produced by vitamin D3. However, the more lipophilic ethyl of ferulic and caffeic acid were capable of inducing the differentiation of HL-60 cells, as well as enhancing the maturation produced by vitamin D3. Curcumin caused a marked reduction in NF-kappa B activity in nuclear extracts of HL-60 cells exposed to this agent in the presence or absence of vitamin D3, supporting the possibility that NF-kappa B may be a factor in the regulation of the state of differentiation of leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9112258

Source DB:  PubMed          Journal:  Oncol Res        ISSN: 0965-0407            Impact factor:   5.574


  9 in total

1.  Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.

Authors:  Hagar Sharabani; Eugene Izumchenko; Qing Wang; Rita Kreinin; Michael Steiner; Zeev Barvish; Michael Kafka; Yoav Sharoni; Joseph Levy; Milan Uskokovic; George P Studzinski; Michael Danilenko
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

2.  The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.

Authors:  Irene Bobilev; Victoria Novik; Itai Levi; Ofer Shpilberg; Joseph Levy; Yoav Sharoni; George P Studzinski; Michael Danilenko
Journal:  Cancer Biol Ther       Date:  2011-02-01       Impact factor: 4.742

3.  Cellular redox state and activating protein-1 are involved in ascorbate effect on calcitriol-induced differentiation.

Authors:  G López-Lluch; M V Blázquez; R Pérez-Vicente; A Macho; M I Burón; F J Alcaín; E Muñoz; P Navas
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

4.  Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.

Authors:  Ayelet Shabtay; Hagar Sharabani; Zeev Barvish; Michael Kafka; Doron Amichay; Joseph Levy; Yoav Sharoni; Milan R Uskokovic; George P Studzinski; Michael Danilenko
Journal:  Oncology       Date:  2008-10-14       Impact factor: 2.935

5.  Resistance to 1,25D-induced differentiation in human acute myeloid leukemia HL60-40AF cells is associated with reduced transcriptional activity and nuclear localization of the vitamin D receptor.

Authors:  Edward Garay; Robert Donnelly; Xuening Wang; George P Studzinski
Journal:  J Cell Physiol       Date:  2007-12       Impact factor: 6.384

6.  Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts.

Authors:  Janice García-Quiroz; Rocío García-Becerra; Clara Santos-Cuevas; Gerardo J Ramírez-Nava; Gabriela Morales-Guadarrama; Nohemí Cárdenas-Ochoa; Mariana Segovia-Mendoza; Heriberto Prado-Garcia; David Ordaz-Rosado; Euclides Avila; Andrea Olmos-Ortiz; Sofía López-Cisneros; Fernando Larrea; Lorenza Díaz
Journal:  Cancers (Basel)       Date:  2019-11-06       Impact factor: 6.639

7.  Cell-Type-Specific Effects of Silibinin on Vitamin D-Induced Differentiation of Acute Myeloid Leukemia Cells Are Associated with Differential Modulation of RXRα Levels.

Authors:  Rina Wassermann; Victoria Novik; Michael Danilenko
Journal:  Leuk Res Treatment       Date:  2012-05-20

Review 8.  Curcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.

Authors:  Stefanie Kewitz; Ines Volkmer; Martin S Staege
Journal:  Cancer Growth Metastasis       Date:  2013-08-08

Review 9.  New insights into therapeutic activity and anticancer properties of curcumin.

Authors:  Abir Kumar Panda; Dwaipayan Chakraborty; Irene Sarkar; Tila Khan; Gaurisankar Sa
Journal:  J Exp Pharmacol       Date:  2017-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.